Company intelligence / Profile preview

Serenno Medical

Valley Lee, Maryland, United States

Ownership: Private
Development stage: Other

Overview

The Serenno system has been successfully tested in human clinical trials and is FDA approved, currently in mass production stages. The system provides continuous urine output monitoring to enable early detection of Acute Kidney Injury in hospitalized patients, improving AKI prediction and fluid management.

Therapeutic areas: Nephrology
Modalities: Device
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Serenno Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serenno Medical.

Explore the full profile